7.74
price down icon3.13%   -0.25
after-market Handel nachbörslich: 7.77 0.03 +0.39%
loading
Schlusskurs vom Vortag:
$7.99
Offen:
$7.98
24-Stunden-Volumen:
276.97K
Relative Volume:
0.79
Marktkapitalisierung:
$182.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.07M
KGV:
-37.27
EPS:
-0.2077
Netto-Cashflow:
$-44.93M
1W Leistung:
-3.61%
1M Leistung:
-5.03%
6M Leistung:
-20.78%
1J Leistung:
-29.01%
1-Tages-Spanne:
Value
$7.74
$7.985
1-Wochen-Bereich:
Value
$7.55
$8.18
52-Wochen-Spanne:
Value
$4.81
$13.88

Cybin Inc Stock (CYBN) Company Profile

Name
Firmenname
Cybin Inc
Name
Telefon
908 764 8385
Name
Adresse
100 King Street West, Suite 5600, Toronto
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CYBN's Discussions on Twitter

Vergleichen Sie CYBN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CYBN
Cybin Inc
7.74 184.03M 0 -52.07M -44.93M -0.2077
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Cybin Inc Stock (CYBN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Guggenheim Buy
2021-11-19 Herabstufung Maxim Group Buy → Hold

Cybin Inc Aktie (CYBN) Neueste Nachrichten

pulisher
Jul 28, 2025

Cybin Inc. Schedules Virtual Annual General Meeting for August 2025 - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

What are Cybin Inc. company’s key revenue driversFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Cybin Inc. in the next 12 monthsInvest confidently with real-time data analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Cybin Inc. stock attracting strong analyst attentionMaximize your portfolio’s growth potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Cybin Inc. stock expected to show significant growthPre Market Trend Scanner With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Cybin Inc. stock overvalued or undervaluedConsistently superior profits - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What institutional investors are buying Cybin Inc. stockAchieve consistent returns with proven methods - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Cybin Inc.Access high-yield investment alerts now - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Cybin Inc. stockInvest smarter with daily market updates - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell Cybin Inc. stock in 2025Extraordinary performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

How Cybin Inc. stock performs during market volatilitySolid Return Trade Selections - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Cybin Inc. stockSuperior portfolio returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Cybin Inc. Stock Analysis and ForecastFree Capital Efficiency Planning - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Cybin Inc. a good long term investmentExceptional growth trajectory - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Cybin, Inc: CYB003 Vs. GH001Duration, Durability and Protocol Execution - Smartkarma

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Cybin Inc. stock pricePowerful market insights - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Cybin Inc. stock benefit from AI tech trendsFree Predictions - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

I can have 5% loss. - AInvest

Jul 24, 2025
pulisher
Jul 21, 2025

(CYBN) Proactive Strategies - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 21, 2025

High-Risk, High-Reward Stocks With Serious Momentum: 5 Stocks to Consider - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Cybin Inc: CYB003 Phase 3 Program Continues to Progress on Plan - Smartkarma

Jul 21, 2025
pulisher
Jul 20, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jul 20, 2025
pulisher
Jul 18, 2025

Don't Trip. These Psychedelic Stocks May Have Some Life in Them Yet - US News Money

Jul 18, 2025
pulisher
Jul 18, 2025

Wall Street Analysts See an 831.44% Upside in Cybin Inc. (CYBN): Can the Stock Really Move This High? - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

UK MHRA approves Cybin’s trial of CYB003 for major depressive disorder - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Three High-Risk, High-Reward Stocks in AI, Biotech, and Autonomous Vehicles - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin's EMBRACE Study: A Pivotal Step in Psychedelic-Driven Mental Healthcare Innovation - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin receives UK MHRA approval to commence EMBRACE study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin Secures UK Approval for Pivotal Depression Study - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin receives UK approval for second pivotal depression study By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Cybin receives UK approval for second pivotal depression study - Investing.com Australia

Jul 17, 2025

Finanzdaten der Cybin Inc-Aktie (CYBN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Kapitalisierung:     |  Volumen (24h):